Tokyo, March 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060880) titled 'A study on the characteristics of taste disorders induced by selective P2X3 receptor antagonists in patients with asthmatic refractory cough' on March 10.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya City University
Condition:
Condition - asthma
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the qualitative characteristics of taste disorders following gefapixant administration in patients with asthmatic refractory chronic cough
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1.Adult patients diagnosed with asthmatic refractory chronic cough between January 2021 and December 2025.
2.Patients who received P2X3 receptor antagonists for 6 months.
3.Patients who completed both cough- and taste-related questionnaires as well as electrogustometry tests.
Key exclusion criteria - 1. Patients deemed ineligible for this study by the investigators or research staff.
Target Size - 10
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 02 Month 22 Day
Date of IRB - 2026 Year 03 Month 02 Day
Anticipated trial start date - 2026 Year 03 Month 02 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069666
Disclaimer: Curated by HT Syndication.
